Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep;37(9):e1156-e1160.
doi: 10.1111/jdv.19165. Epub 2023 May 12.

Dupilumab for atopic dermatitis during pregnancy and breastfeeding: Clinical experience in 13 patients

H Escolà  1 , I Figueras-Nart  2 , M Bonfill-Orti  2 , N Coll Puigserver  3 , A Martin-Santiago  4 , M Rodríguez Serna  5 , M C Sánchez Hernández  6 , J L Sanz-Cabanillas  7 , R Taberner  8 , V Zaragoza-Ninet  9 , R M Pujol  1 , L Curto-Barredo  1
Affiliations

Dupilumab for atopic dermatitis during pregnancy and breastfeeding: Clinical experience in 13 patients

H Escolà et al. J Eur Acad Dermatol Venereol. 2023 Sep.
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Lobo Y, Lee RC, Spelman L. Atopic dermatitis treated safely with dupilumab during pregnancy: a case report and review of the literature. Case Rep Dermatol. 2021;13:248-56.
    1. Kage P, Simon JC, Treudler R. A case of atopic eczema treated safely with dupilumab during pregnancy and lactation. J Eur Acad Dermatol Venereol. 2020;34:e256-7.
    1. Vestergaard C, Wollenberg A, Barbarot S, Christen-Zaech S, Deleuran M, Spuls P, et al. European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period. J Eur Acad Dermatol Venereol. 2019;33:1644-59.
    1. European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP). Dupixent CHMP assessment report on extension of marketing authorisation and an extension of indication variation February 2019. [last accessed 2022 Dec 1]. Available from: https://www.ema.europa.eu/en/documents/variation-report/dupixent-h-c-439...
    1. Khamisy-Farah R, Damiani G, Kong JD, Wu JH, Bragazzi NL. Safety profile of dupilumab during pregnancy: a data mining and disproportionality analysis of over 37,000 reports from the WHO individual case safety reporting database (VigiBase™). Eur Rev Med Pharmacol Sci. 2021;25:5448-51.

LinkOut - more resources